Skip to main content
Medi-Caps Ltd. logo

Medi-Caps Ltd. — Investor Relations & Filings

Ticker · 523144 ISIN · INE442D01010 BSE.NS Manufacturing
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-05-23 Audit Report / Informat…
Country IN India
Listing BSE.NS 523144

About Medi-Caps Ltd.

https://www.medicaps.com/

Medi-Caps Ltd. specializes in the manufacturing and distribution of empty hard gelatin capsules. The company provides a wide range of capsule sizes and types, including specialized variants designed for pharmaceutical and nutraceutical applications. Its product portfolio features standard sizes such as 00, 0, 1, 2, 3, and 4, alongside specialized options like liquid-fill and preservative-free capsules. The organization emphasizes precision engineering and adheres to international quality standards, including Good Manufacturing Practices (GMP). By leveraging advanced manufacturing technologies, the company ensures high-speed filling performance and consistency across its production lines. Medi-Caps Ltd. serves a global clientele, focusing on delivering reliable containment solutions for various medicinal and dietary supplement formulations.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for F. Y. 2025-26
Audit Report / Information Classification · 75% confidence The document is a cover letter and the full text of an "Annual Secretarial Compliance Report" issued by a practicing company secretary under SEBI Listing Regulations. It is not an Annual Report (10-K) or earnings release, but a standalone regulatory/compliance audit certificate relating to SEBI LODR obligations. Under our taxonomy, standalone audit or compliance certificates belong in Audit Report / Information (AR), not in Annual Reports or Regulatory Filings. Hence, it is classified as AR.
2026-05-23 English
Standalone and consolidated audited financial results for the quarter and year ended 31.03.2026 approved by the Board in their 01/2026-27 Board meeting held on 21.05.2026.An extract of ....
Regulatory Filings Classification · 95% confidence The document is a brief BSE regulatory filing under SEBI LODR Reg. 47 enclosing newspaper clippings of the approved audited financial results. It does not contain the results themselves or substantive financial data, nor is it a full report—rather it is a compliance submission. This fits the general “Regulatory Filings” category (RNS) as a regulatory announcement/compliance document.
2026-05-23 English
Re-appointment of internal Auditor for the financial year 2026-27
Regulatory Filings Classification · 72% confidence The document is a formal disclosure under Regulation 30 of SEBI LODR regarding the re-appointment of the company’s internal auditor. It is not a full audit report, financial statement, dividend notice, or board meeting minutes, nor is it an AGM presentation or earnings release. It is a routine regulatory announcement of a corporate event (re-appointment of internal auditor) required by stock exchange listing rules. This falls under the catch-all category for miscellaneous regulatory filings.
2026-05-21 English
Submission of audited standalone and consolidated financial results for the quarter and year ended 31.03.2026
Interim / Quarterly Report Classification · 85% confidence The document is a Regulation 30 SEBI LODR filing that presents and attaches the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026, together with the auditor’s report and detailed financial statements (statement of assets & liabilities, cash flows, etc.). It is not the full Annual Report (10‐K) package, nor simply an earnings summary (ER); it contains full audited financials and qualifies as a periodic financial report. Per our definitions, this is an Interim/Quarterly Report (IR) type disclosure. FY 2026
2026-05-21 English
With reference to the above captioned subject and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that, Board ....
Interim / Quarterly Report Classification · 85% confidence The document is an exchange filing made under SEBI Listing Regulations to announce and publish the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with the auditor’s report and full financial statements (P&L, balance sheet, cash flows). It contains detailed line‐item financial data rather than only key highlights, but it is not the company’s full annual report (which would include MD&A, corporate overview, governance, etc.). Therefore, it best matches the definition of an Interim/Quarterly Report (IR): a comprehensive report for a period shorter than a full fiscal year with substantive financial statements. FY 2026
2026-05-21 English
Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1.Consider and approve the Standalone ....
Regulatory Filings Classification · 85% confidence The document is a formal notice filed under SEBI Listing Regulations regarding the scheduling of a Board of Directors meeting to consider audited financial results. It contains no actual financial statements or report content, nor does it announce management changes or voting results. It is a regulatory announcement/filing under the Listing Obligations and Disclosure Requirements and thus falls under the general “Regulatory Filings” category (RNS).
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.